As such, it is not expected that any pressure applied on the parasite by this HDAC inhibitor as it cycles through the mosquito will result in resistance to any existing antimalarial drug, placing the use of a chromobacteria-based strategy against anopheline mosquitoes as an important additional tool for an integrated approach to malaria control. Here, HDAC9 is linked to malaria.